Acucela

Acucela

  • About Us
  • Therapeutic Approach
  • Pipeline
  • News
  • Careers
  •  
  • News
  • Press Releases
  • Press Coverage
  • Publications
  • Dr. Ryo's Blog

 

 

Media Inquiries
Please contact:

 

Keri Mattox

Pure Communications

> email

215.791.0105

 

Press Releases

 

2010

2009

2008

2007

2006

2004

2003


 

11/07/08 Acucela to Present at the Rodman & Renshaw Healthcare Conference

10/28/08 Acucela to Present at the 2008 BIO Investor Forum

09/04/08 Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry
               AMD

09/04/08 Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide for
               Dry Eye

06/12/08 Acucela to Present at BIO International Convention

06/03/08 Acucela Doses First Subject in Phase I Trial for Age-Related Macular Degeneration

05/20/08 Acucela to Present at C21 Bioventures Conference

05/07/08 Acucela Files Investigational New Drug Application -- Orally-available Small Molecule for
               Dry Form of AMD

04/29/08 Acucela Presents Preclinical Data from Retinopathy Study Demonstrating Improvement in
               Retinal Abnormalities

04/22/08 Acucela Announces Presentation of Data in Preclinical Study of Retinopathy

03/18/08 Acucela to Present at INVEST NORTHWEST 2008 Conference

 

© 2010 Acucela Inc.Japanese Site 日本語

  • Contact Us
  • Sitemap
  • Search
  • Privacy
  • Terms of Use